Insider Trading History of Baker Bros. Advisors (gp) Llc


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Baker Bros. Advisors (gp) Llc since year 2005. The trader's CIK number is 1580575. At the time of the last reporting, Baker Bros. Advisors (gp) Llc was the Director of Genomic Health Inc . (stock ticker symbol GHDX). See this page for all insider trading activities at Genomic Health Inc .

Note that in the past Baker Bros. Advisors (GP) LLC also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Baker Bros. Advisors (gp) Llc since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-02-27 GHDX Genomic Health Inc Sale 39,109 76.43 2,989,139
2019-02-26 GHDX Genomic Health Inc Option Ex 16,500 17.59 290,235
2019-02-26 GHDX Genomic Health Inc Sale 8,650 77.97 674,440
2019-01-28 GHDX Genomic Health Inc Sale 46,477 70.95 3,297,636
2019-01-23 GHDX Genomic Health Inc Sale 37,512 71.99 2,700,338
2019-01-24 GHDX Genomic Health Inc Sale 79,403 72.02 5,718,604
2019-01-25 GHDX Genomic Health Inc Sale 91,916 72.20 6,636,610
2018-11-27 GHDX Genomic Health Inc Sale 138,610 74.00 10,257,001
2018-11-26 GHDX Genomic Health Inc Sale 39,675 74.20 2,944,043
2018-11-16 GHDX Genomic Health Inc Sale 87,395 77.00 6,729,851
2017-03-24 BLCM Bellicum Pharmaceuticals, Inc Buy 166,666 12.00 1,999,992
2016-11-17 NVTA Invitae Corp Buy 733,333 6.00 4,399,998
2016-06-07 MRTX Mirati Therapeutics, Inc. Sale 296,200 9.44 2,795,535
2016-06-08 MRTX Mirati Therapeutics, Inc. Sale 158,100 9.21 1,456,417
2016-06-09 MRTX Mirati Therapeutics, Inc. Sale 545,058 9.48 5,166,604
2016-05-11 NTLA Intellia Therapeutics, Inc. Buy 200,000 18.00 3,600,000
2016-04-01 ACAD Acadia Pharmaceuticals Inc Buy 302,900 28.18 8,536,933
2016-03-30 ACAD Acadia Pharmaceuticals Inc Buy 462,546 26.08 12,064,124
2016-03-31 ACAD Acadia Pharmaceuticals Inc Buy 683,644 26.70 18,255,345
2016-03-15 INCY Incyte Corp Buy 400,000 66.08 26,431,599
2016-03-17 INCY Incyte Corp Buy 400,000 61.36 24,543,600
2016-03-17 INCY Incyte Corp Option Ex 60,000 3.86 231,600
2015-09-16 INCY Incyte Corp Option Ex 4,623,926 .00 0
2015-09-16 MRTX Mirati Therapeutics, Inc. Buy 150,000 45.00 6,750,000
2015-05-11 INCY Incyte Corp Option Ex 60,000 7.68 460,800
2015-02-13 IDRA Idera Pharmaceuticals, Inc. Buy 5,333,333 3.75 19,999,998
2015-01-07 GEVA Trimeris Inc Buy 1,000,000 94.19 94,190,000
2014-05-21 INCY Incyte Corp Option Ex 30,000 7.02 210,600
2014-03-05 ACAD Acadia Pharmaceuticals Inc Buy 526,316 28.50 15,000,006

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baker Bros. Advisors (gp) Llc (Director of Genomic Health Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.